What's new

Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 8, Status: Authorised

Apr 3, 2025 - 16:05
 0
Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 8, Status: Authorised
Human medicines European public assessment report (EPAR): Ronapreve, casirivimab,imdevimab, Date of authorisation: 12/11/2021, Revision: 8, Status: Authorised
Read More

Tags:

Previous Article

Vanrafia, 2nd drug in Novartis' IgAN troika, crosses FDA finish line in payday f...

Next Article

Avangrid commissions 202MW Powell Creek solar project in Ohio

Related Posts

Applications for new human medicines under evaluation: ...

Feb 10, 2025  0

ICH M11 Technical Specification - Updated step 2b

Mar 18, 2025  0

Investigation of bioequivalence - Scientific guideline

Investigation of bioequivalence - Scientific guideline

Feb 26, 2025  0